Can Conventional ECG Technology Capture Fetal Cardiac Activity?

Part of paid clinical trials in Seattle, Washington.

Sponsor
University of Washington
Study ID
NCT03111173
Status
Recruiting
Apply to this trial

Conditions

  • Fetal Monitoring

Eligibility Criteria

Sex
FEMALE
Age
18 Years - 55 Years
Healthy Volunteers
Not accepted

Interventions

  • Holter Device — DEVICE
    MyECG E3.80 Holter Recorder

Study Details

This is a feasibility study for a new application for capturing fetal cardiac activity. The objective of this study is to determine if it is feasible to capture a fetal ECG signal using a Holter ECG device. As comparison we will use a standard Doppler Fetal Heart Rate (FHR) device.

Key Dates

Start date
Jun 2, 2017
Status verified
Jan 2024
Primary completion
Jun 30, 2025
Completion
Dec 31, 2026

Study Design

Enrollment
50 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY

Arms

  • Other: Holter device
    Holter device to be attached to a Singleton or twin pregnant women at 32 weeks gestation to full term

Primary Outcome Measure

Successful extraction of fetal ECG from the maternal abdominal ECG signal [ Time Frame: 12 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of WashingtonSeattleWashington98105
Martin G Frasch, MD, PhD
[email protected]
206-543-5892
Amy Gest, MPA
[email protected]
206-359-1961
Martin Frasch, MD, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Seattle, WA

By research site
University of Washington· Seattle, WA